Financials • Specialty Insurers
$9.01 ▼ -1.40
(-13.45%)
MKT CAP: $551.2M • VOL: 9.2K
52W L $8 52W H $94
ROARABLE / RQD
E • 23/100
PIOTROSKI
2 / 9
AIFU // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $79.6M | $247.8M | $450.5M |
| YoY Revenue Growth % | -67.9% | -45.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$5.6M | -$59.7M | $27.6M |
| Operating Margin % | -7.0% | -24.1% | 6.1% |
| Net Income (GAAP) | -$325.4M | $62.3M | $39.5M |
| EBITDA (Normalized) | -$5.2M | -$58.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.3M | $19.6M | $14.3M |
| Capital Expenditures (CapEx) | $477.0K | $1.2M | — |
| Free Cash Flow (FCF) | -$2.8M | $18.4M | $14.3M |
| FCF Margin % | -3.5% | 7.4% | 3.2% |
| Return on Invested Capital (ROIC %) | -6.9% | -14.6% | — |
| Cash & Short-Term Equivalents | $4.4M | $26.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $68.4M | $348.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AIFU.